Sanchez Edward, Pastuszak Alexander W, Khera Mohit
Scott Department of Urology, Baylor College of Medicine, Houston, TX, USA.
Scott Department of Urology, Baylor College of Medicine, Houston, TX, USA; Center for Reproductive Medicine, Baylor College of Medicine, Houston, TX, USA.
Transl Androl Urol. 2017 Feb;6(1):28-36. doi: 10.21037/tau.2016.10.01.
Erectile dysfunction (ED) is the most common male sexual dysfunction, and shares many risk factors with systemic conditions including cardiovascular disease (CVD) and the metabolic syndrome (MetS). ED is considered to be an independent risk factor for CVD and can be a harbinger of future cardiovascular events. Given this relationship, each encounter for ED should be viewed by healthcare providers as an opportunity to screen for CVD and other comorbid conditions, including the MetS, that can significantly affect a man's overall health. While universally accepted screening guidelines are lacking, expert panels do recommend an approach to risk stratification in men with ED. In this review, we discuss the current state of understanding of the relationship between ED, the MetS, and CV risk, and how this impacts the approach to the patient presenting with ED.
勃起功能障碍（ED）是最常见的男性性功能障碍，与包括心血管疾病（CVD）和代谢综合征（MetS）在内的全身性疾病有许多共同的危险因素。ED被认为是CVD的独立危险因素，并且可能是未来心血管事件的先兆。鉴于这种关系，医疗保健提供者应将每次ED就诊视为筛查CVD和其他合并症（包括MetS）的机会，这些合并症会显著影响男性的整体健康。虽然缺乏普遍接受的筛查指南，但专家小组确实推荐了一种对ED男性进行风险分层的方法。在这篇综述中，我们讨论了目前对ED、MetS和心血管风险之间关系的理解现状，以及这如何影响对ED患者的处理方法。
